Login / Signup

Flupyranochromene, a novel inhibitor of influenza virus cap-dependent endonuclease, from Penicillium sp. f28743.

Manabu YamasakiMasayuki IgarashiRyuichi SawaChisato NosakaMaya UmekitaMasaki HatanoTomoyuki KimuraKiyoko IijimaNaoki TakizawaTaira KatoKiyohisa MizumotoAkio Nomoto
Published in: The Journal of antibiotics (2019)
Influenza virus RNA polymerase has cap-dependent endonuclease activity that produces capped RNA fragments for priming viral mRNA synthesis. This enzymatic activity is essential for viral propagation, but it is not present in any host cellular enzyme, making it an attractive target for the development of anti-influenza drugs. Here, we isolated a novel inhibitor of cap-dependent endonuclease, named flupyranochromene, from the fermentation broth of the fungus Penicillium sp. f28743. Structural analysis revealed that this compound bears a putative pharmacophore that chelates divalent metal ion(s) present in the endonuclease active site in the PA subunit of the polymerase. Consistently, in vitro endonuclease assays showed that flupyranochromene exerts its inhibitory effects by blocking endonucleolytic cleavage by the PA subunit of viral RNA polymerase complex.
Keyphrases
  • dna repair
  • sars cov
  • dna damage
  • high throughput
  • molecular docking
  • molecular dynamics simulations